Bring HAL to your university or NHS trust.

HAL is a virtual patient simulator that lets students and trainees practise consultations, clinical reasoning and management planning at scale — with structured feedback against national clinical guidelines, and clinician oversight built in.

Endorsement

Society of Musculoskeletal Medicine Endorsed by the Society of Musculoskeletal Medicine

HAL's musculoskeletal content is reviewed by clinical educators from the Society of Musculoskeletal Medicine.

Where institutions use HAL

Three places HAL slots cleanly into existing teaching pathways.

Pre-placement preparation

Send students into clinical placements having already practised dozens of consultations. Less anxiety, more confident first encounters with real patients.

OSCE rehearsal

Standardised, repeatable consultation practice in the lead-up to clinical exams. Each student gets the same depth of practice, regardless of placement allocation.

Pre-clinical and CPD

Reinforce clinical reasoning early in the curriculum, or use HAL for qualified-clinician CPD when staff are moving into a new specialty or returning to practice.

Built by an NHS clinician and educator

HAL Education was founded by Simon Head, an Advanced Practice Physiotherapist working in the NHS, with experience teaching and assessing clinical reasoning across both undergraduate and postgraduate settings.

HAL exists because the first time many clinicians get to properly practise a consultation is with a real patient. That puts pressure on clinicians, introduces clinical risk to patients, and adds inefficiency to already-stretched health services. HAL aims to change that, using AI to train clinicians rather than replace them.

  • Advanced Practice Physiotherapist, NHS
  • Clinical educator, Society of Musculoskeletal Medicine
  • NHS England Digital Fellow
  • Founder, HAL Education
98%
of HAL consultations reviewed by clinicians rated as “no harm if advice followed in clinical practice”.
Read the clinical-quality report →

Get in touch

Drop us a line and we'll get back to you with pricing, collaboration and research opportunities, and the latest clinical-quality data.